Glucagon-like peptide 1 receptor agonist use is associated with reduced risk for glaucoma | British Journal of Ophthalmology

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via AAO

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Clinical science

Glucagon-like peptide 1 receptor agonist use is associated with reduced risk for glaucoma

Online download statistics by month:

Online download statistics by month: August 2021 to March 2023

	Abstract	Full	Pdf
Aug 2021	53	35	24
Sep 2021	135	114	58
Oct 2021	2309	34	19
Nov 2021	567	18	6
Dec 2021	413	6	2
Jan 2022	465	41	18
Feb 2022	380	14	6
Mar 2022	465	19	10
Apr 2022	534	14	13
May 2022	484	24	9
Jun 2022	561	16	4
Jul 2022	545	19	3
Aug 2022	423	17	2
Sep 2022	463	15	6
Oct 2022	501	21	7
Nov 2022	500	11	4
Dec 2022	379	7	1
Jan 2023	845	36	22
Feb 2023	710	31	25
Total	10732	492	239